Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1.
第一作者:
Thomas J,Ow
第一单位:
Department of Otorhinolaryngology-Head and Neck Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.;Department of Pathology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.;Albert Einstein Cancer Center, Bronx, NY, USA.
作者:
DOI
10.18632/oncotarget.26563
PMID
30728900
发布时间
2026-02-26
基金项目
P30 CA016056/CA/NCI NIH HHS/United States
R01 CA178394/CA/NCI NIH HHS/United States
K23 DE027425/DE/NIDCR NIH HHS/United States
T32 GM007491/GM/NIGMS NIH HHS/United States
K12 CA132783/CA/NCI NIH HHS/United States
UL1 TR002556/TR/NCATS NIH HHS/United States
P30 CA013330/CA/NCI NIH HHS/United States
- 浏览10
Oncotarget
494-510页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



